6960-22-1
Chemical Structure
6-Methylnicotinamide
- CAS. Nr.: 6960-22-1
- Formula:C7H8N2O
- Molecular Weight:136.15
IUPAC Name: 6-methylnicotinamide
InChIKey: IJXDURUAYOKSIS-UHFFFAOYSA-N
SMILES: NC(C1=CN=C(C)C=C1)=O
Biological Activity: 6-Methylnicotinamide is a derivative of Nicotinamide (HY-B0150). 6-Methylnicotinamide coordinates with undercoordinated Pb2+ ions through its carbonyl group, passivating Pb-related defects. 6-Methylnicotinamide reduces trap density and non-radiative recombination in the perovskite absorber layer while inducing interfacial dipole formation. 6-Methylnicotinamide enhances the hydrophobicity, grain size, and environmental, thermal, and photostability of perovskite films. 6-Methylnicotinamide induces complementation of VP16-deficient HSV-1 replication and stimulates immediate-early gene expression. 6-Methylnicotinamide is upregulated in the acute phase of intracerebral hemorrhage and may exacerbate neurological injury. 6-Methylnicotinamide can be used for research on intracerebral hemorrhage and herpes simplex virus type 1 infection[1][2][3].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
6-Methylnicotinamide | 99.98% | 6-Methylnicotinamide is a derivative of Nicotinamide (HY-B0150). 6-Methylnicotinamide coordinates with undercoordinated Pb2+ ions through its carbonyl group, passivating Pb-related defects. 6-Methylnicotinamide reduces trap density and non-radiative recombination in the perovskite absorber layer while inducing interfacial dipole formation. 6-Methylnicotinamide enhances the hydrophobicity, grain size, and environmental, thermal, and photostability of perovskite films. 6-Methylnicotinamide induces complementation of VP16-deficient HSV-1 replication and stimulates immediate-early gene expression. 6-Methylnicotinamide is upregulated in the acute phase of intracerebral hemorrhage and may exacerbate neurological injury. 6-Methylnicotinamide can be used for research on intracerebral hemorrhage and herpes simplex virus type 1 infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
6-Methylnicotinamide (Standard) | ≥98% | 6-Methylnicotinamide (Standard) is the analytical standard of 6-Methylnicotinamide (HY-W015815). This product is intended for research and analytical applications. 6-Methylnicotinamide is a derivative of Nicotinamide (HY-B0150). 6-Methylnicotinamide coordinates with undercoordinated Pb2+ ions through its carbonyl group, passivating Pb-related defects. 6-Methylnicotinamide reduces trap density and non-radiative recombination in the perovskite absorber layer while inducing interfacial dipole formation. 6-Methylnicotinamide enhances the hydrophobicity, grain size, and environmental, thermal, and photostability of perovskite films. 6-Methylnicotinamide induces complementation of VP16-deficient HSV-1 replication and stimulates immediate-early gene expression. 6-Methylnicotinamide is upregulated in the acute phase of intracerebral hemorrhage and may exacerbate neurological injury. 6-Methylnicotinamide can be used for research on intracerebral hemorrhage and herpes simplex virus type 1 infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Liu L, et al. Manipulating electron density distribution of nicotinamide derivatives toward defect passivation in perovskite solar cells[J]. Advanced Energy Materials, 2023, 13(30): 2300610.
- [2]. Hu E, et al. Temporal metabolomic alteration in rat brains of experimental intracerebral hemorrhage. Brain research bulletin. 2021 May;170:234-245. [Content Brief]
- [3]. Preston CM, et al. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Virology. 1998 Sep 30;249(2):418-26.
